A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation
暂无分享,去创建一个
J. Pearson | Thomas Naderer | J. Vince | M. Herold | Daniel S. Simpson | H. Tye | Tirta M. Djajawi | N. Lalaoui | Timothy A. Gottschalk | J. Emery | Ashley Weir | Gilu Abraham | K. Lawlor | Sebastian A Hughes | Stephanie A Conos | Mary Speir | Isabella Y. Kong | Rebecca L. Ambrose | Pankaj Deo | Ashlyn Pascoe | Edwin D. Hawkins
[1] H. Sampath,et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. , 2022, Immunity.
[2] Si Ming Man,et al. Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway , 2022, Immunity.
[3] Erinna F. Lee,et al. Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer , 2021, Biochemical Society transactions.
[4] J. Pearson,et al. Evolutionary dynamics of multidrug resistant Salmonella enterica serovar 4,[5],12:i:- in Australia , 2021, Nature Communications.
[5] D. Brownfield,et al. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity , 2021, Science Advances.
[6] Thomas Naderer,et al. Bacterial outer membrane vesicles and host cell death signaling. , 2021, Trends in microbiology.
[7] Q. You,et al. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy. , 2021, European journal of medicinal chemistry.
[8] Laura F. Dagley,et al. The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation , 2021, Nature Communications.
[9] J. Garlick,et al. Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. , 2021, Immunity.
[10] L. Gangoda,et al. Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis , 2021, Cell Death & Differentiation.
[11] M. A. Wemyss,et al. The diverse roles of RIP kinases in host-pathogen interactions , 2020, Seminars in Cell & Developmental Biology.
[12] Jian Li,et al. Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation , 2020, Nature Microbiology.
[13] K. E. Lawlor,et al. RIP-roaring inflammation: RIPK1 and RIPK3 driven NLRP3 inflammasome activation and autoinflammatory disease. , 2020, Seminars in cell & developmental biology.
[14] A. Strasser,et al. Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection , 2020, Immunity.
[15] L. Gangoda,et al. The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophils , 2020, Cell Death & Disease.
[16] S. Tait,et al. Mitochondrial DNA in inflammation and immunity , 2020, EMBO reports.
[17] T. Kaufmann,et al. Impact of BH3-mimetics on Human and Mouse Blood Leukocytes: A Comparative Study , 2020, Scientific Reports.
[18] P. Vogel,et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease , 2019, The Journal of experimental medicine.
[19] M. Pasparakis,et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis , 2019, Nature.
[20] Rohit Reja,et al. Activity of caspase-8 determines plasticity between cell death pathways , 2019, Nature.
[21] J. Mullikin,et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease , 2019, Nature.
[22] L. Komuves,et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis , 2019, Nature.
[23] Steven L Salzberg,et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.
[24] Kaiwen W. Chen,et al. Extrinsic and intrinsic apoptosis activate pannexin‐1 to drive NLRP3 inflammasome assembly , 2019, The EMBO journal.
[25] A. Lew,et al. Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model , 2019, Nature Immunology.
[26] A. Letai,et al. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins , 2019, Nature Reviews Molecular Cell Biology.
[27] Daniel S. Simpson,et al. Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation , 2018, Journal of leukocyte biology.
[28] A. Mócsai,et al. Myeloid-Specific Deletion of Mcl-1 Yields Severely Neutropenic Mice That Survive and Breed in Homozygous Form , 2018, The Journal of Immunology.
[29] Dhruv Chauhan,et al. BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1β Maturation in Macrophages. , 2018, Cell reports.
[30] Si Ming Man,et al. The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β Activation. , 2018, Cell reports.
[31] D. Green,et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection , 2018, Proceedings of the National Academy of Sciences.
[32] J. Bertin,et al. Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death , 2018, Science.
[33] S. Akira,et al. Infection with flaviviruses requires BCLXL for cell survival , 2018, PLoS pathogens.
[34] Gordon K Smyth,et al. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads , 2018, bioRxiv.
[35] M. Gaestel,et al. Differentiated macrophages acquire a pro-inflammatory and cell death–resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1 , 2018, The Journal of Biological Chemistry.
[36] J. Klco,et al. TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation , 2018, The Journal of experimental medicine.
[37] G. Dougan,et al. Outer membrane vesicles from Neisseria gonorrhoeae target PorB to mitochondria and induce apoptosis , 2018, PLoS pathogens.
[38] Thomas Naderer,et al. Targeting apoptosis pathways in infections , 2018, Journal of leukocyte biology.
[39] D. Russell,et al. Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation , 2017, Cell.
[40] T. Aittokallio,et al. Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins , 2017, Viruses.
[41] A. Oberst,et al. Mitochondrial permeabilisation engages NF-κB dependent anti-tumour activity under caspase deficiency , 2017, Nature Cell Biology.
[42] A. Strasser,et al. The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice , 2017, Cell Death and Differentiation.
[43] D. Vaux,et al. XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1β Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation. , 2017, Cell reports.
[44] D. Green,et al. Caspase‐8: regulating life and death , 2017, Immunological reviews.
[45] D. Bachovchin,et al. Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages. , 2017, Cell chemical biology.
[46] A. Strasser,et al. Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment , 2017, Cell Death and Differentiation.
[47] E. Miao,et al. Programmed cell death as a defence against infection , 2017, Nature Reviews Immunology.
[48] D. Vaux,et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner , 2017, Proceedings of the National Academy of Sciences.
[49] D. Vaux,et al. Cycloheximide Can Induce Bax/Bak Dependent Myeloid Cell Death Independently of Multiple BH3-Only Proteins , 2016, PloS one.
[50] M. Kaparakis-Liaskos,et al. Bacterial membrane vesicles: Biogenesis, immune regulation and pathogenesis , 2016, Cellular microbiology.
[51] A. Strasser,et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models , 2016, Nature.
[52] A. Oberst,et al. Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death , 2016, PLoS pathogens.
[53] G. Häcker,et al. Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis , 2016, Cell Death and Disease.
[54] M. Kelliher,et al. CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN. , 2016, Cell reports.
[55] V. Dixit,et al. Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.
[56] Stefan P. Glaser,et al. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia , 2016, Science Translational Medicine.
[57] Jonathan L. Schmid-Burgk,et al. Human Monocytes Engage an Alternative Inflammasome Pathway. , 2016, Immunity.
[58] Stefan P. Glaser,et al. Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis , 2016, Nature Microbiology.
[59] J. Vier,et al. The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling , 2016, Cell Death and Disease.
[60] P. Brož,et al. Caspase‐11 activates a canonical NLRP3 inflammasome by promoting K+ efflux , 2015, European journal of immunology.
[61] S. Kummerfeld,et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.
[62] T. Cai,et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.
[63] Maryam Rashidi,et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL , 2015, Nature Communications.
[64] K. Schroder,et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.
[65] P. Czabotar,et al. Characterisation of a novel A1-specific monoclonal antibody , 2014, Cell Death and Disease.
[66] D. Vaux,et al. Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non‐apoptotic caspase‐8 is required for inflammasome priming , 2014, EMBO reports.
[67] A. Strasser,et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. , 2014, Cell reports.
[68] D. Vaux,et al. PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK 1-and RIPK 3-dependent manner , 2014 .
[69] J. Vince,et al. Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria? , 2014, Biochimica et biophysica acta.
[70] L. Komuves,et al. Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis , 2014, Science.
[71] G. Smyth,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[72] D. Zamboni,et al. Subversion of inflammasome activation and pyroptosis by pathogenic bacteria , 2013, Front. Cell. Infect. Microbiol..
[73] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[74] K. Schroder,et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC , 2013, Cell Death and Differentiation.
[75] A. Mildner,et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.
[76] Andrew Kovalenko,et al. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. , 2013, Immunity.
[77] L. Lam,et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.
[78] D. Green,et al. Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1β and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner , 2012, The Journal of Immunology.
[79] Moshe Arditi,et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.
[80] J. Tschopp,et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. , 2012, Immunity.
[81] R. Xavier,et al. CASPASE 8 inhibits programmed necrosis by processing CYLD , 2011, Nature Cell Biology.
[82] R. Strasser,et al. Generation of Mature Murine Monocytes from Heterogeneous Bone Marrow and Description of Their Properties , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[83] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[84] Guy S. Salvesen,et al. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis , 2011, Nature.
[85] M. Robinson,et al. A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.
[86] J. Opferman,et al. Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function. , 2009, Blood.
[87] Xiaodong Wang,et al. TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.
[88] S. Fesik,et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. , 2008, Cancer research.
[89] Yide Mei,et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. , 2007, Cellular signalling.
[90] You-Wen He,et al. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. , 2007, Blood.
[91] C. Scott,et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. , 2006, Cancer cell.
[92] I. Berberich,et al. The Stability and Anti-apoptotic Function of A1 Are Controlled by Its C Terminus* , 2006, Journal of Biological Chemistry.
[93] C. Gélinas,et al. Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor , 2005, Cell Death and Differentiation.
[94] S. Korsmeyer,et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.
[95] D. Vaux,et al. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die , 2004, The Journal of cell biology.
[96] J. Trapani,et al. A new quantitative assay for cytochrome c release in apoptotic cells , 2003, Cell Death and Differentiation.
[97] K. Roth,et al. Mcl-1 deficiency results in peri-implantation embryonic lethality. , 2000, Genes & development.
[98] P. Schotte,et al. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1 (cid:2) maturation by caspase-8 , 2008 .
[99] S. Janssens,et al. Brief Definitive Report Stimulation of Toll-like Receptor 3 and 4 Induces Interleukin-1  Maturation by Caspase-8 , 2022 .